Aurobindo Pharma Subsidiary Acquires 80% Stake in A1 Biochem Group to Build CRDMO Platform
Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has approved the acquisition of an 80% stake in the Contract Research Services business of the A1 Biochem Group. The transaction, valued at an enterprise value of USD 17 million on a debt-free and cash-free basis, aims to bolster the Company's presence in the life cycle of Active Pharmaceutical Ingredients (API).The acquisition targets the CRO business of the A1 Biochem Group, which provides high-quality chemistry services to pharmaceutical companies, biotechs, and academic institutions. These services include custom synthesis, medicinal chemistry, route...